SCHEMBL7865571

SCHEMBL7865571

Cc1ccc2c(c1)Cc1ccccc1CN2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.63
HSD17B10 Q99714 1/20 0.63
GAA P10253 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B3 P37058 1/20 0.36
HTR5A P47898 3/20 0.36
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ROS1 P08922 1/20 0.34
CDK5 Q00535 1/20 0.34
ACVR1 Q04771 1/20 0.34
LRRK2 Q5S007 1/20 0.34
PARP10 Q53GL7 1/20 0.34
PARP11 Q9NR21 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7866841 0.88 ALOX15 (0.67) ALOX15HSD17B10GAANPSR1HSD17B3
SCHEMBL7865592 0.86 HSD17B10 (0.63) ALOX15HSD17B10GAANPSR1HSD17B3
SCHEMBL19257866 0.82
SCHEMBL14294948 0.82 HTR5A (0.43) ALOX15HSD17B10GAAHTR5AKDM4E
SCHEMBL2988989 0.79 ALOX15 (0.63) ALOX15HSD17B10GAANPSR1ROS1
SCHEMBL7341760 0.79 ALOX15 (0.63) ALOX15HSD17B10GAANPSR1HSD17B3
SCHEMBL2087881 0.78 ALOX15 (1.00) ALOX15HSD17B10GAANPSR1HSD17B3
SCHEMBL31546300 0.78 ALOX15 (1.00) ALOX15HSD17B10GAANPSR1HSD17B3
SCHEMBL11537959 0.78 ROS1 (0.47) ALOX15HSD17B10GAAHTR5AKDM4E
SCHEMBL19142112 0.76 PARP10 (0.42) GAAHTR5AALDH1A1ROS1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0789701-B1 SUBSTITUTED TETRACYCLIC AZEPINE DERIVATIVES WHICH HAVE AFFINITY FOR 5-HT2 RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2001-02-07 EP disclosed
US-5552399-A TREATMENT OR PREVENTION OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS, GASTROINTESTINAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1996-09-03 US disclosed
WO-1996014320-A1 SUBSTITUTED TETRACYCLIC AZEPINE DERIVATIVES WHICH HAVE AFFINITY FOR 5-HT2 RECEPTORS JANSSEN PHARMACEUTICA N.V. (BE) 1996-05-17 WO disclosed